ALC 2.53% 8.1¢ alcidion group limited

There are actually direct competitors against Alcidion each...

  1. 530 Posts.
    lightbulb Created with Sketch. 824
    There are actually direct competitors against Alcidion each product solution, Nervecentre against Patientrack, CARPS against Smartpage and Telstra Health's Patient Flow Manager against Miya Patient Flow/Precision. However, like you said there is no company in the current market can offer all three products as a whole, Alcidion is the only company offer the complete product suite which gives them much better negotiating power and cost advantages. Another one of key advantages is the product suite can be sold as a whole or single solution to any hospital groups. In the recent contract win for Dartford and Gravesham NHS Trust, Alcidion has beaten Nervecentre in the final step of tendering process. One of main strengths that MKM Health has - they have one of the best market lead data integration teams in ANZ , basically they can help hospital groups to integrate new software that they purchased into their own IT systems. And also Miya Precision can now apply 3rd parties algorithms (like CSRIO or any other universities/institutions developed) into consistent real time data. Kate did mention that the next step would be re-branding the Alcidion core product Miya Precision which give customers much clear picture what Alcidion offer.
    Last edited by willchang409: 21/03/19
 
watchlist Created with Sketch. Add ALC (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.002(2.53%)
Mkt cap ! $108.7M
Open High Low Value Volume
7.9¢ 8.2¢ 7.9¢ $71.89K 889.7K

Buyers (Bids)

No. Vol. Price($)
4 159179 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 38940 1
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
ALC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.